Why is drug discovery so complex? I Professor Chun-wa Chung FMedSci on the Molecular Mode of Action

acmedsci published this video item, entitled “Why is drug discovery so complex? I Professor Chun-wa Chung FMedSci on the Molecular Mode of Action” – below is their description.

Professor Chun-wa Chung FMedSci talks about why an early insight into the optimal Molecular Mode of Action (MMOA) allows us to hone and speed up our search for new medicines.

Choosing the right therapeutic target is really important in drug discovery but also very difficult. However, it is not enough to choose the right target in order to determine the exact molecule needed to restore normal function. Professor Chung uses the analogy that identifying the defective component may not be sufficient to repair a machine, especially if you can’t repair the part.

We also need to understand the Molecular Mode of Action (MMOA) to find out which part of the protein molecule a drug needs to bind to, whether this binding needs to inhibit or activate protein function, and whether there are other functions relevant to what we want the drug to do.

This talk was part of the event “Talks from new Fellows 2022”.

Professor Chun-wa Chung FMedSci is Senior Director of Structural and Biophysical Science at GlaxoSmithKline. Drug discovery starts with good lead compounds. As an internationally recognised expert in her field Professor Chung pioneered many of the integrated biophysical and structural approaches for hit confirmation and fragment-based drug discovery now firmly embedded within medicinal sciences throughout industry and academia. Her broad impact has been recognised by an extensive publication record, her status as committee member of the European Laboratory Research & Innovation Group, and frequently chairing and speaking at international meetings.

Find out more about Professor Chung: https://acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/fellow/Chun-Wa-Chung-0033z00002qIMV6AAO

The Academy of Medical Sciences is the independent, expert voice of biomedical and health research in the UK. Our Fellowship comprises the most influential scientists in the UK and worldwide, drawn from the NHS, academia, industry, and the public service. Our mission is to improve the health of people everywhere by creating an open and progressive research sector. We do this by working with patients and the public to influence policy and biomedical practice, strengthening UK biomedical and health research, supporting the next generation of researchers through funding and career development opportunities, and working with partners globally.

Find the Academy of Medical Sciences online:

Website: http://acmedsci.ac.uk/

Twitter: http://twitter.com/AcMedSci

Facebook: http://www.facebook.com/acmedsci

Instagram: http://www.instagram.com/acmedsci/

LinkedIn: https://www.linkedin.com/company/acmedsci/

acmedsci YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - acmedsci

The Academy of Medical Sciences (Acmedsci) is an independent body in the UK representing the diversity of medical science. Their mission is to advance biomedical and health research and its translation into benefits for society.

Recent from acmedsci:

Success from the south: the rotavirus vaccine story and its lessons 1

Success from the South: the rotavirus vaccine story and its lessons

2023 FORUM Sir Colin Dollery Lecture: How to innovate in health – applying implementation sciences

25 and up: Emerging Research Leaders’ Summit – Birmingham, October 2023

In This Story: GlaxoSmithKline

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England.

Established in 2000, by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world’s sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co.

GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi.

The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016, it had a market capitalisation of £81 billion (about US$107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.

The company developed the first malaria vaccine, RTS,S, which it said in 2014, it would make available for five percent above cost. Legacy products developed at GSK include several listed in the World Health Organization‘s List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine, and zidovudine.

In 2012, GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States and agreed to pay a US$3 billion (£1.9bn) settlement. It was the largest health-care fraud case to date in that country and the largest settlement by a drug company.

2 Recent Items: GlaxoSmithKline

Why the human genome could be health care’s holy grail

GSK CEO Emma Walmsley on beating Q4 earnings

In This Story: NHS

The National Health Service is the publicly funded healthcare system in England, and one of the four National Health Service systems in the United Kingdom. It is the second largest single-payer healthcare system in the world after the Brazilian Sistema Único de Saúde.

The NHS was founded on 5th July 1948. Current annual budget: £134 billion (2019).

3 Recent Items: NHS

‘National incident’ declared over measles outbreak

Friday Night with Niall Paterson live: Japan is the fifth country to land a spacecraft on the moon

Rishi Sunak heckled by member of the public over state of NHS

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.